Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Price to Earnings (2020 - 2022)

Updated

Northwest Biotherapeutics' (NWBO) Price to Earnings was 5.35 for Q3 2022, up 28.9% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Price to Earnings (2020 - 2022) Analysis & Trends

For FY2021, Price to Earnings at Northwest Biotherapeutics was 3.71.

  • The Q3 2022 figure ranks as the highest quarterly Price to Earnings since Q1 2020.
  • Per Business Quant data, the three quarters before Q3 2022 came in at 4.15 (Q2 2022), 3.83 (Q1 2022) and 3.62 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 5.35
Jun 30, 2022 4.15
Mar 31, 2022 3.83
Dec 31, 2021 3.62
Mar 31, 2020 34.07
API Access

Northwest Biotherapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=NWBO&period=max&api_key=YOUR_API_KEY